Where to Inject Tirzepatide: Injection Sites for Mounjaro and Zepbound

Quick Answer

Tirzepatide (Mounjaro and Zepbound) is injected subcutaneously — into the fat tissue under the skin — at one of three approved sites: abdomen, outer thigh, or upper arm. The abdomen is recommended for most patients. Rotate sites each week to prevent scar tissue and maintain consistent drug absorption.

Approved Injection Sites

Both Mounjaro and Zepbound use the same injection sites. Tirzepatide is a subcutaneous injection — it goes into fat tissue, not muscle:

Abdomen (recommended first choice)

Location: At least 2 inches (5 cm) away from the navel in any direction
Area: The band of soft tissue between the bottom of the ribcage and the top of the hip bones
Avoid: The navel, any existing scars, stretch marks, bruised areas, or irritated skin
Why it's preferred: Largest subcutaneous fat area, easiest to access without assistance

Outer Thigh

Location: The middle outer portion of the thigh (not the inner or front)
Easy to see during self-injection
Equivalent absorption to the abdomen

Back of the Upper Arm

Location: The fatty tissue behind the triceps muscle
Hardest to self-administer — typically requires a partner or significant flexibility
Absorption is equivalent to other sites

Step-by-Step Injection Technique

Remove the pen from the refrigerator 30 minutes before use. Room-temperature injections are noticeably more comfortable than cold ones.
Wash your hands with soap and water.
Choose your injection site (rotating from last week).
Clean the area with an alcohol swab. Let it dry fully before injecting.
Remove the pen cap and check the medication is clear (not cloudy or discolored).
Hold the pen against your skin — the Zepbound/Mounjaro pen is a KwikPen auto-injector that doesn't require needle attachment. Press the pen against the injection site.
Press the injection button. You'll hear a click. Hold the pen in place for at least 10 seconds to ensure complete dose delivery.
Remove the pen and check the yellow indicator has moved to confirm the full dose was delivered.
Dispose of the pen in a sharps container. Each Mounjaro/Zepbound pen is single-use.

Tirzepatide Pen vs. Vial: Injection Differences

Auto-injector pen (standard): The Mounjaro and Zepbound pens are self-contained single-use devices. They don't require needle attachment or dose dialing. Simply uncap, press to skin, and activate.

Self-draw vials (LillyDirect): The LillyDirect self-pay format is a multi-dose vial requiring patient-drawn dosing with a syringe. This requires:

1 mL insulin syringe with a 29–31 gauge, 4–6 mm needle
Drawing the exact prescribed volume from the vial
Injecting subcutaneously at a 90° angle
Holding for 6 seconds before removing

Vial dosing requires more careful technique than pens. Patients switching from pens to vials should receive training from their prescriber or pharmacist.

Rotation Schedule

Repeat injections in the same location cause lipodystrophy — scar tissue buildup that impairs absorption and creates lumps. A consistent rotation schedule prevents this.

Simple 4-week rotation:

Week 1: Right abdomen
Week 2: Left abdomen
Week 3: Right outer thigh
Week 4: Left outer thigh
Week 5: Return to right abdomen

Within each site, vary the exact spot (upper vs. lower abdomen, different area of the thigh). Keeping a brief log of your last injection site helps maintain rotation.

Managing Injection Site Reactions

Common (expected) reactions:

Mild redness or bruising at the injection site — resolves within 24–72 hours
Slight itching immediately after injection
Small raised area that flattens within an hour

Reduce reactions by:

Allowing pen to reach room temperature before injecting
Using smooth, confident injection technique (hesitation increases bruising)
Ensuring the injection site is fully dry after alcohol swab
Not rubbing the injection site after withdrawal

Contact your prescriber for:

Redness that spreads or grows beyond the injection area
Significant swelling, warmth, or pus (signs of infection)
Hardened lumps that don't resolve (lipodystrophy from insufficient rotation)
Any rash or hives beyond the local injection site

Can You Inject in the Same Site as Other Medications?

If you use insulin alongside Mounjaro:

Yes, the same three sites can be used for both
Do not inject Mounjaro and insulin into the same spot on the same day
Stagger injection sites (right abdomen for Mounjaro, left abdomen or thigh for insulin, or different times)

Bottom Line

Tirzepatide is injected subcutaneously at the abdomen, outer thigh, or upper arm — the abdomen is preferred for most patients. The Mounjaro/Zepbound pens are single-use auto-injectors that simplify technique. Rotate injection sites weekly to prevent scar tissue. Letting the pen warm to room temperature is the single most impactful factor for injection comfort.